Proteomic analysis of bone proteins adsorbed onto the surface of titanium dioxide  by Sugimoto, Keisuke et al.
Biochemistry and Biophysics Reports 7 (2016) 316–322Contents lists available at ScienceDirectBiochemistry and Biophysics Reportshttp://d
2405-58
n Corr
E-mjournal homepage: www.elsevier.com/locate/bbrepProteomic analysis of bone proteins adsorbed onto the surface
of titanium dioxide
Keisuke Sugimoto a, Shuhei Tsuchiya b,n, Masahiro Omori a, Ryo Matsuda a, Masahito Fujio a,
Kensuke Kuroda c, Masazumi Okido c, Hideharu Hibi a
a Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan
b Nagoya University Hospital Oral and Maxillofacial Surgery, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan
c EcoTopia Science Institute, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8603, Japana r t i c l e i n f o
Article history:
Received 7 April 2016
Received in revised form
20 June 2016
Accepted 12 July 2016







08/& 2016 The Authors. Published by Elsevier
esponding author.
ail address: t-shuhei@med.nagoya-u.ac.jp (S. Ta b s t r a c t
Osseointegration is the structural and functional connection between bone tissues and implants such as
titanium dioxide (TiO2). The bone-TiO2 interface is thought to contain proteoglycans. However, ex-
haustive analysis of the proteins in this layer has not been performed. In this study, we evaluated the
bone protein adhered on the surface of TiO2 comprehensively. Pig bone protein was extracted by se-
quential elutions with guanidine, 0.1 M EDTA, and again with guanidine. The proteins obtained from
these extractions were allowed to adhere to an HPLC column packed with TiO2 and were eluted with
0.2 M NaOH. The eluted proteins were identiﬁed by LC/MS/MS and included not only proteoglycans but
also other proteins such as extracellular matrix proteins, enzymes, and growth factors. Calcium de-
positions were observed on TiO2 particles incubated with bone proteins, guanidine-extracted proteins
adhered to TiO2 displayed signiﬁcantly high amounts of calcium depositions.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Osseointegration refers to a direct bone-to-metal surface con-
nection without interposition of ﬁbrous tissue [1]. Based on this
concept, implant treatment has become one of the prosthetic
treatment for replacing missing teeth. Almost all dental implants
are made of titanium dioxide (TiO2), because of its superior bio-
compatibility and mechanical resistance to force [2]. Osseointe-
gration is mainly evaluated by observing the bone interface using
light microscopy or by comparing the bone-to-implant surface
contact rate in vivo [1]. However, a layer at the bone-TiO2 interface
has also been reported based on transmission electron microscopy
[3,4]. This layer was suggested to be essential for osseointegration.
Previous reports speculated that this zone was ﬁlled with glyco-
saminoglycans (GAGs) as observed by immunohistochemical
analysis and ruthenium red staining [4,5].
A previous biochemical study attempted to identify the bio-
molecules adsorbed on TiO2 [5]. GAG chondroitin-4-sulfate (C4S)
was adsorbed onto the surface of TiO2 powder via calcium ions [6].
However, the proteoglycans adsorbed on TiO2 were not released
upon EDTA-mediated calcium ion chelation, invalidating the
electrostatic bridge hypothesis. These histological and biochemicalB.V. This is an open access article u
suchiya).data are several decades old and have previously been summar-
ized elsewhere [7].
Recently, TiO2 has been used in proteomics for chromato-
graphy-based protein puriﬁcation because of its high afﬁnity for
phosphopeptides [8]. TiO2 has the capacity to bind not only to
phosphorylated peptides but also to non-phosphorylated or acidic
peptides, excluding hydroxycarboxylic acids, 2,5 dihydroxybenzoic
acid, and glycolic acid [9]. The mechanism that binds TiO2 and the
adherent proteins has not been fully elucidated. Gertler and col-
leagues investigated the binding mechanism and relative binding
strength between peptides and a TiO2 surface using chromato-
graphy [10]. This biochemical analysis was performed with pep-
tides or trypsin-digested proteins that were no longer in their
three-dimensional conformation, and therefore did not represent
the in vivo behavior of proteins. Recently, Tsuchiya and colleagues
reported that secreted proteins derived from cultured bone mar-
row stromal cells, including extracellular matrix (ECM) proteins,
cytokines, growth factors, and cellular components, were capable
of adhering to TiO2 particles [11]. Another study revealed that the
proteins attached to TiO2 were related to cell adhesion, transport,
coagulation, immune response, and cytokines [12]. Taken together,
these previous reports demonstrate that various proteins can be
immobilized on TiO2 surfaces, and the TiO2 chromatography sys-
tem is a useful proteomics tool. Research is needed to identify the
speciﬁc bone-related proteins that are immobilized on the TiO2
surface.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in vivo proteins on the surface of TiO2. To clarify the phenomenon
of osseointegration, this study was a new trial to use in vivo pro-
teins for proteome analysis of proteins adhered on TiO2.
To achieve this, chromatography was performed with com-
mercially available TiO2 particles as a carrier. Immobilized proteins
were analyzed via sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and liquid chromatography-tandem
mass spectrometry (LC/MS/MS). The mineralization capacity of
these proteins was also evaluated by Field emission scanning
electron microscopy with X-ray spectroscopy (SEM).2. Materials and methods
2.1. Preparation of bone powder
Pig calvaria were surgically extracted with a hammer and chisel
from the skulls of 24 pigs (6-month-old) with in minutes after
sacriﬁce at the Nambu Market (Nagoya City Central Wholesale
Market, Nagoya, Japan). The calvaria were cut into small pieces
(approximately 2010 mm) and the tissue was powdered using a
grinder (ASONE, Osaka, Japan).
2.2. Dissociative extraction procedure
The procedure for sequential extraction of bone proteins was
performed at 4 °C as described previously [13]. A 50 g bone pow-
der sample was taken from each density fraction. Two 48-h ex-
tractions, each at a volume:weight ratio of 50:1, were performed at
4 °C with a solution of 4 M guanidine hydrochloride (GuHCl),
50 mM Tris-HCl (pH 7.4) containing a protease inhibitor cocktail
(1 mM AEBSF, 0.8 mM aprotinin, 50 mM bestatin, 15 mM E-64, 20 mM
leupeptin, and 10 mM pepstatin (Calbiochem EMD Chemicals Inc.,
Gibbstown, NJ, USA)), and 1 mM 1,10-phenanthroline (Sigma-Al-
drich, Tokyo, Japan). Insoluble material was pelleted by cen-
trifugation and the supernatant was designated the ﬁrst guanidine
extract (G1S). The remaining insoluble bone powder was washed
twice for 30 min in phosphate-buffered saline (PBS) at a volume:
weight ratio of 200:1. The samples were then extracted twice with
0.5 M EDTA/50 mM Tris-HCl (pH 7.4) containing the same protease
inhibitor cocktail as previously described, each at 100X volume, for
48 h. Insoluble material was pelleted by centrifugation and the
supernatant was designated the EDTA extract (E-Sup). The PBS
wash procedure was repeated and the tissue residues were again
extracted twice at 4 °C with the guanidine extraction solution for
48 h at a volume: weight ratio of 50:1. Residual insoluble material
was pelleted by centrifugation. Following centrifugation, the su-
pernatant was designated the second guanidine extract (G2S). All
extractions were then dialyzed exhaustively in distilled water at
4 °C.
2.3. Protein adherence on TiO2 and elution using chromatography
Before chromatographic analysis, it was conﬁrmed that G1S,
E-Sup, and G2S proteins were adhered on the TiO2 powder (par-
ticle size, 45 mm) (WAKO, Osaka, Japan) and were subsequently
eluted with 0.2 M NaOH (Supplementary Fig. 1). A Bio-Scale MT10
Column (1288 mm) (Bio-Rad, Tokyo, Japan) packed with TiO2
powder was used for chromatography. The packed columns were
washed consecutively with water and 0.2 M NaOH to desorb sur-
face contaminants. The columns were then pre-equilibrated with
0.01 M PBS. Chromatography was performed on an Agilent 1220
Inﬁnity HPLC system (Agilent Technologies, Tokyo, Japan). Lyo-
philized protein samples were dissolved in running buffer
(10 mg/mL), centrifuged at 5000 g for 5 min, and ﬁlteredthrough a 0.45-μm syringe ﬁlter (Thermo Fisher Scientiﬁc K.K.,
Nagoya, Japan) to remove aggregates prior to injection into the
column. Five milliliters of supernatant was injected into the TiO2
column at a ﬂow rate of 0.02 mL/min to attain a 40 min retention
time for adsorption and ﬂow-through of non-adhesive proteins
[14]. After 40 min, the ﬂow rate was increased to 3.0 mL/min. PBS
(10 mM) lacking Mg2þ and Ca2þ (pH 7.4), was used as the ad-
sorption (running) medium. Elution was performed using gra-
dients of 0.2 M NaOH and monitored at 254 nm.
2.4. SDS-PAGE
A 100 mg sample of each of the G1S, E-Sup, and G2S extracts
was resuspended in 50 μL SDS sample buffer (0.125 mM Tris-HCl,
4% SDS, 10% sucrose, 0.01% bromophenol blue, and 10% 2-mer-
captoethanol) and heated to 95 °C for 1 min. Proteins were sepa-
rated in a NIHON EIDO system (NIHON EIDO, Tokyo, Japan) using
12% Tris-Tricine gels, alongside a protein ladder (Spectra Multi-
color Broad Range Protein Ladder, Thermo Fisher Scientiﬁc K.K.) to
estimate molecular weights. Proteins were stained with Coomassie
Brilliant Blue (CBB R-250) and 0.01% Stains-All (Sigma Chemical
Co., St Louis, MO).
2.5. Protein identiﬁcation with liquid chromatography-tandem mass
spectrometry (LC/MS/MS)
Proteins in the elution fractions were digested with trypsin
(Promega KK, Tokyo, Japan) for 16 h at 37 °C after reduction, al-
kylation, demineralization, and concentration. Nanoelectrospray
tandem mass analysis was performed using an LTQ Orbitrap XL
mass spectrometry system (Thermo Fisher Scientiﬁc Inc., Wal-
tham, MA) combined with a Paradigm MS4 HPLC System (Mi-
chrom BioResources Inc., Auburn, CA). Samples were injected onto
the Paradigm MS4 HPLC System equipped with an L-column2 ODS
0.1 mm in diameter and 150 mm in length (Chemicals Evaluation
and Research Institute, Japan). Reversed-phase chromatography
was performed with a linear gradient (5% B at 0 min; 50% B after
100 min) of solvent A (2% acetonitrile with 0.1% formic acid) and
solvent B (90% acetonitrile with 0.1% formic acid) at an estimated
ﬂow rate of 500 nL/min. Ionization was performed by an ADVANCE
Spray Source (Michrom BioResources Inc., Auburn, CA) at 150 °C
with a capillary voltage of 1.7 kV. A precursor ion scan was carried
out using a mass to charge ratio (m/z) of 400–2000 prior to MS/MS
analysis. Multiple MS/MS spectra were submitted to the Mascot
program, version 2.4.1 (Matrix Science Inc., Boston, MA) for the
MS/MS ion search.
2.6. Mineralization capacity of proteins adhered on TiO2
About 100 μg each of G1S, E-Sup, and G2S proteins were dis-
solved in separate 100-μL aliquots of PBS, added to TiO2 particles,
then incubated overnight at 37 °C. As a negative control, a sample
of TiO2 particles was immersed in PBS alone. After incubation, TiO2
particles were rinsed three times with PBS, and 100 μL of 1 mM
CaCl2 was added for another overnight incubation at 37 °C. Field
emission scanning electron microscopy with x-ray spectroscopy
(JEOL-JSM7610F SEM) was performed to conﬁrm the presence of
calcium deposits on the TiO2 particle surfaces for the G1S, E-Sup,
G2S, and control groups. The amount of calcium deposition was
measured with an Alizarin Red S (ARS) Staining Quantiﬁcation
assay (ScienCell Research Laboratories, Carlsbad, USA). Brieﬂy,
40 mM ARS was added to the TiO2 particles for 30 min at 37 °C.
After incubation, semiquantiﬁcation of ARS in TiO2 particles was
measured by acetic acid extraction and neutralization with am-
monium hydroxide, followed by colorimetric detection at 405 nm.
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3.1. TiO2 chromatography
The results of TiO2 chromatography of the G1S, E-Sup, and G2S
proteins are shown in Fig. 1A–F. Most of the proteins injected into
the column eluted in the ﬂow-through fraction (Fig. 1A, C and E).
However, several smaller peaks were detected after elution with
0.2 M NaOH (Fig. 1B, D and F). For the G1S proteins, only one peak
was detected in the ﬂow-through fraction (Fig. 1A), while 6 peaks
were detected in the eluted fraction (Fig. 1B). For E-Sup proteins,
2 peaks were detected in the ﬂow-through fraction (Fig. 1C) and
5 peaks were detected in the eluted fraction (Fig. 1D). For the G2S
proteins, one peak was detected in the ﬂow-through fraction
(Fig. 1E) and 4 peaks were detected in the fraction (Fig. 1F).
3.2. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE)
Fig. 2A–F shows the 12% gel electrophoretic proﬁles of peaksFig. 1. Chromatogram of the ﬂow-through fraction of (A) G1S, (C) E-Sup, and (E) G2S prot
elution fraction of (B) G1S, (D) E-Sup, and (F) G2S protein from a column packed with
Fig. 2. SDS electrophoretic pattern of peaks on a 12% gel detected in the ﬂow-through an
Stains-All (B, D, F).from the TiO2 chromatography performed on the G1S, E-Sup, and
G2S proteins. Several bands were detected with CBB and Stains-All
staining. Proteins with various molecular weights were detected in
each experimental group. The expression pattern of each sample
derived from the peaks was not signiﬁcantly different between the
three experimental groups.3.3. Protein identiﬁcation with liquid chromatography-tandem mass
spectrometry (LC/MS/MS)
Using LC/MS/MS, the proteins from each fraction that adhered
to TiO2 were identiﬁed. From the 0.2 M NaOH elution peaks, 151,
116, and 43 proteins were detected from the G1S sample, E-Sup
sample, and G2S sample, respectively. Table 1 shows re-
presentative proteins detected in the three experimental groups
based on their Exponentially Modiﬁed Protein Abundance Index
(emPAI) value.ein from a column packed with titanium powder. Chromatogram of the 0.2 M NaOH
titanium powder. All peaks were detected with a UV monitor at 254 nm.
d elution fraction of experimental groups stained with Coomassie Blue (A, C, E), and
Table 1
List of Proteins Identiﬁed on TiO2 Particles.
G1S proteins immobilized on TiO2, as detected by LC/MS/MS
♯ Accesion no Protein emPAI
1 P02067 Hemoglobin subunit beta 30.17
2 P08835 Serum albumin 21.95
3 P089571 Serotransferrin 21.67
4 P01846 Ig lambda chain 14.46
5 O97788 Fatty acid-binding protein, adipocyte 5.55
6 P50828 Hemopexin 4.26
7 Q8SPS7 Haptoglobin 4.21
8 P01965 Hemoglobin subunit alpha 4
9 Q2KIS7 Tetranectin 2.5
10 P18648 Apolipoprotein A-I 2.24
11 P50447 Alpha-1-antitrypsin 2.12
12 P19620 Annexin A2 1.76
13 Q49I35 Galectin-1 1.53
14 P23284 Peptidyl-prolyl cis-trans isomerase 1.44
15 P02080 Hemoglobin subunit beta-C(NA) 1.43
16 P18650 Apolipoprotein E 1.19
17 Q5E9F7 Coﬁlin-1 1.11
18 P52552 Peroxiredoxin-2 1.07
19 P01972 Hemoglobin subunit alpha-1/2 0.99
20 Q5E956 Triosephosphate isomerase 0.94
21 P35700 Peroxiredoxin-1 0.88
22 P08758 Annexin A5 0.82
23 P00795 Cathepsin D 0.77
24 Q61398 Procollagen C-endopeptidase enhancer 1 0.76
25 Q29549 Clusterin 0.32
E-Sup proteins immobilized on TiO2, as detected by LC/MS/MS
♯ Accesion no Protein emPAI
1 P20112 SPARC 9.43
2 P08493 Matrix Gla protein 4.17
3 O46390 Biglycan 4.08
4 Q19AZ8 Prothrombin 3.8
5 P0DMA9 Apolipoprotein A-I 3.1
6 P14460 Fibrinogen alpha chain (Fragment) 2.89
7 Q9GLP2 Vitamin K-dependent protein C 2.17
8 P48819 Vitronectin 2.15
9 P79281 Pleiotrophin 1.96
10 Q27972 Chondroadherin 1.83
11 Q3ZBN5 Asporin 1.76
12 P16293 Coagulation factor IX 1.72
13 P62935 Peptidyl-prolyl cis-trans isomerase 1.63
14 P45845 Protein-lysine 6-oxidase 1.62
15 Q2KJH6 Serpin H1 1.52
16 Q05717 Insulin-like growth factor-binding protein 5 1.21
17 P36955 Pigment epithelium-derived factor 1.01
18 Q62009 Periostin 0.93
19 Q863H1 Secreted frizzled-related protein 2 0.87
20 F1N152 Serine protease HTRA1 0.85
21 P32262 Antithrombin-III 0.85
22 P0C225 Osteocalcin 0.79
23 P78539 Sushi repeat-containing protein SRPX 0.51
24 P19879 Mimecan 0.51
25 O01305 Calcium vector protein 0.46
G2S proteins immobilized on TiO2, as detected by LC/MS/MS
♯ Accesion no Protein emPAI
1 Q9XSD9 Decorin 7.52
2 Q711S8 Secreted phosphoprotein 24 4.26
3 P29700 Alpha-2-HS-glycoprotein 3.32
4 P50609 Fibromodulin 1.69
5 P14287 Osteopontin 1.33
6 Q05443 Lumican 1.1
7 P12273 Prolactin-inducible protein 0.86
8 Q9XSJ7 Collagen alpha-1(I) chain 0.82
9 P02465 Collagen alpha-2(I) chain 0.75
10 Q28178 Thrombospondin-1 0.59
11 Q9TTY1 Metalloproteinase inhibitor 2 0.53
12 Q29116 Tenascin 0.5
13 P20908 Collagen alpha-1(V) 0.46
14 Q28944 Cathepsin L1 0.46
Table 1 (continued )
G2S proteins immobilized on TiO2, as detected by LC/MS/MS
15 A6QLP7 Translocon-associated protein subunit alpha 0.25
16 P04785 Protein disulﬁde-isomerase 0.21
17 P07589 Fibronectin 0.19
18 P51888 Prolargin 0.18
19 P05009 Interferon alpha-C 0.18
20 Q15198 Platelet-derived growth factor receptor-like protein 0.09
21 Q6AY22 Spermatogenesis-associated protein 1 0.07
22 Q8BMK4 Cytoskeleton-associated protein 4 0.06
23 P08003 Protein disulﬁde-isomerase A4 0.05
24 P08253 72 kDa type IV collagenase 0.05
25 Q95116 Thrombospondin-2 0.03
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Fig. 3 shows the mineralization capacity of the proteins that
adhered on TiO2 particles. TiO2 particles incubated with proteins
from the G1S and G2S fractions displayed increased calcium de-
position compared to TiO2 particles incubated with PBS or the
E-Sup fraction (Fig. 3A). As measured by the Alizarin Red S Staining
Quantiﬁcation Assay, more calcium depositions were observed on
TiO2 particles treated with G1S and G2S proteins in comparison to
the PBS control group. Few calcium depositions were seen in the
TiO2 particles treated with E-Sup protein (Fig. 3B).4. Discussion
The speciﬁc bone-related proteins adhered on TiO2 are not
completely understood. Previous reports on the bone-TiO2 inter-
face rely on histological observations, but this method is not able
to comprehensively identify the adherent biomolecules. In this
report, native proteins were extracted from pig bone and sub-
jected to TiO2 particle binding using chromatography. Adhered
proteins were analyzed using SDS-PAGE and LC/MS/MS. This
analysis revealed that the interface between bone and TiO2 existed
a sort of proteins, such as extracellular matrix, enzyme, and
growth factor and some of the adhered proteins showed miner-
alization capacity.
Evaluation of the proteins that adhered to TiO2 particles was
performed with chromatography. In contrast to the current ﬁnd-
ings, a previous report analyzing TiO2 adhesive proteins using
chromatography detected only one peak [15]. However, in that
study, bovine metatarsal proteins were dissolved in 2 M urea,
which denatures proteins and disrupts their conformation [16]. In
the current study, extracted proteins were dissolved in PBS before
analysis so that their conformation would be maintained closer to
their actual in vivo state. Thus, it is possible that the buffer caused
the differences in results between this previous report and the
current study. Moreover, the presence of one peak in their study
indicates that this protein fraction was adsorbed on TiO2 with a
certain afﬁnity at a neutral pH, and was released at an alkaline pH.
The presence of multiple peaks during a linear gradient elution
with 0.2 M NaOH buffer indicates that the eluted proteins have
different retention times. This suggests that the analyzed bone
proteins display differences in afﬁnity for TiO2. At about 15% of
0.2 M NaOH (30 mM NaOH), the column was completely eluted.
This is in accordance with results from a previous study that re-
ported complete protein elution using 25 mM NaOH [14]. This
suggests that the adherence strength between TiO2 and the bone
proteins did not depend on protein conformation.
Furthermore, there was substantial overlap between the peaks
found for each experimental group. At the same time, there were
signiﬁcant differences between the chromatograms of all three
Fig. 3. (A) SEM of the calcium depositions of proteins adhered on titanium particles, at 10,000 magniﬁcation. Red arrows refer to calcium depositions. (B) Calcium
deposition quantiﬁcation using the ARS assay. Data are expressed as the mean (n¼3) with error bars representing standard deviations, #po0.05 compared to control, and
*po0.05 compared to E-Sup.
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responsible for the adhesion of proteins on TiO2 is not dependent
on the protein. The gradient conditions of the 0.2 M NaOH elution
buffer were changed in an attempt to improve peak resolution.
However, complete separation of the peaks could not be obtained
(data not shown). Further optimization of the TiO2 carrier column
is required to improve the separation of the protein peaks upon
elution. In this study, the method of chromatography method was
available to evaluate soluble proteins adhered to TiO2. Evaluation
of the insoluble proteins derived from bone could not be per-
formed with chromatography, because samples to analysis with
this chromatography system were limited to soluble molecules.
Further research is required to address the effect of insoluble
proteins adsorption.
SDS-PAGE and LC/MS/MS revealed the presence of a wide
variety of proteins in each of the three experimental fractions. In
the G1S fraction, the most abundant TiO2 adhesive proteins were
albumin and hemoglobin subunit beta, according to the current
emPAI results. These serum proteins are known to adhere to TiO2
[17] and are found in bone tissue upon extraction. However, pre-
vious studies reported that ﬁbronectin was the most abundant
TiO2-adhesive protein in serum [12,18]. This discrepancy can be
explained by the fact that small proteins such as albumin may be
replaced by larger proteins such as ﬁbronectin and ﬁbrinogen
during chromatography, due to an exchange process known as theVroman effect [19]. Additionally, the protein samples analyzed in
the two studies are completely different. While bone tissue and
serum both contain ﬁbronectin, the relative protein content is
different, possibly affecting the degree of ﬁbronectin adsorption on
TiO2.
Previous studies used TiO2 disks to study protein adherence
[20,21]. It is known that, besides structural selectivity, afﬁnity of
large biomolecules can also arise from physical surface properties
including hydrophobicity, topology [21], and charge [20]. Our re-
sults indicate that these factors were different between TiO2 par-
ticles and TiO2 disks.
The ECM components detected, especially biglycan, glycosy-
lated decorin, and chondroitin/dermatan sulfate, which contain
sulfate groups, were negatively charged [22]. The keratin sulfate
proteoglycans ﬁbromodulin, lumican, and mimecan also contain
sulfate groups [23]. A previous report showed that these small
leucine-rich proteoglycans (SLRPs) can adhere to TiO2 [24]. How-
ever, this report was based on in vitro gene expression analysis,
which does not provide direct evidence for the adherence of SLRPs
onto TiO2. This is the ﬁrst report that unequivocally demonstrates
SLRPs adhering to TiO2.
Thrombospondin-1 [25], SPARC [26], osteopontin [27], and te-
nascin [28] are glycoproteins with O- and N-linked glycosylation,
but they have not yet been reported to have sulfate groups. Os-
teopontin was detected in the interface between TiO2 and bone in
K. Sugimoto et al. / Biochemistry and Biophysics Reports 7 (2016) 316–322 321a previous histological analysis [29]. This indicates that sulfate
groups are not necessary for TiO2 adhesion. Furthermore, osteo-
calcin, periostin, and matrix gla protein were also detected. These
proteins play a role in mineralization and do not have a carbohy-
drate chain. Osteocalcin was also previously detected in the
bone-TiO2 interface [29]. Our results are in agreement with these
previous reports and suggest that these proteins, with the excep-
tion of proteoglycan, can be found in the interface between TiO2
and bone.
It was previously suggested that GAGs bind TiO2 via Ca2þ [6].
However, the proteins in this study had the capacity to bind TiO2
in the absence of Ca2þ and Mg2þ , as these ions were not present
in the buffer. This inconsistency was previously reported by Ozawa
and Kasugai (1996) who suggested that proteins from bone mar-
row stromal cells and osteoblasts could adhere on TiO2 in the
absence of these divalent cations [30]. Further research is required
to address the effect of Ca2þ and Mg2þ on TiO2 protein adsorption.
Proteins can have several binding sites, depending on their
conformation and amino acid sequence. Some growth factors that
were detected in this study have the ability to bind proteoglycans
[22], and SLRPs are known to interact with collagen during col-
lagen ﬁbrillogenesis [31]. The protein samples used in this study
were dissolved in 0.01 M PBS (pH 7.4) to mimic an in vivo en-
vironment, and it is therefore possible that the proteins detected
in this study were bound to each other in a complex before ad-
hering to TiO2. Therefore, future investigations should analyze
puriﬁed proteins of interest to evaluate whether they adhere to
TiO2 directly.
The mineralization capacity of the proteins experimentally
found to adhere on TiO2 was evaluated by SEM. In the G1S fraction,
the most abundant protein was albumin. However, several studies
have reported that the presence of albumin decreases the amount
of calcium phosphide precipitate on a Ti surface [32]. The G1S
fraction included not only albumin but also other proteins, and the
ﬁndings suggest that one or several of these other proteins are
involved in the formation of calcium deposits. However, the spe-
ciﬁc protein(s) in G1S that are associated with mineralization were
not identiﬁed and further study is required to determine the
players contributing to increased mineralization. The E-Sup frac-
tion contained calcium-binding proteins such as osteocalcin,
periostin, and matrix gla protein, however, we only found limited
calcium deposition in this fraction. It is possible that the calcium-
binding proteins directly adhere onto TiO2, inhibiting the binding
of calcium. The role of the interaction between calcium-binding
proteins and TiO2 in the mineralization process is unclear and
requires further research. The most abundant protein in the G2S
fraction was the SLRP decorin. SLRPs control the formation and
orientation of collagen ﬁbrils and contribute to mineralization
[33]. A previous study showed that the GAG chain of decorin can
bind calcium [33]; it is possible that decorin contributed to an
increased formation of calcium deposits in comparison to the
control.
Besides using histological analysis, osseointegration has also
been studied by comparing the removal torque or the force ne-
cessary for pushing out implants placed in animals [1,3]. For ob-
vious ethical concerns, these experimental methods are not ap-
propriate to study osseointegration in clinical applications. In
contrast to these invasive methods, which require the removal of
the operated implants from patients, biochemical methods that
detect a given protein proﬁle related to osseointegration cause no
harm to the bone tissue or implant. The current study represents
an important step forward in the development of a biomarker of
osseointegration for clinical application.
To conclude, native proteins were extracted from pig bone in
this study. These proteins were subjected to TiO2 chromatography
and were identiﬁed with LC/MS/MS. We identiﬁed that theinterface between bone and TiO2 existed a sort of proteins, such as
extracellular matrix, enzyme, and growth factor. Interestingly,
except for previously detected proteins, the detected ECM proteins
were not glycosylated. TiO2 incubated with proteins from guani-
dine-extracted proteins displayed increased calcium depositions.
Proteome analysis using TiO2 chromatography is a useful tool for
investigating which bone proteins adhere to TiO2.Acknowledgments
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